Dergi makalesi Açık Erişim
Karoglu-Eravsar, Elif Tugce; Tuz-Sasik, Melek Umay; Karaduman, Aysenur; Keskus, Ayse Gokce; Arslan-Ergul, Ayca; Konu, Ozlen; Kafaligonul, Hulusi; Adams, Michelle M.
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd"> <identifier identifierType="URL">https://aperta.ulakbim.gov.tr/record/270528</identifier> <creators> <creator> <creatorName>Karoglu-Eravsar, Elif Tugce</creatorName> <givenName>Elif Tugce</givenName> <familyName>Karoglu-Eravsar</familyName> </creator> <creator> <creatorName>Tuz-Sasik, Melek Umay</creatorName> <givenName>Melek Umay</givenName> <familyName>Tuz-Sasik</familyName> </creator> <creator> <creatorName>Karaduman, Aysenur</creatorName> <givenName>Aysenur</givenName> <familyName>Karaduman</familyName> </creator> <creator> <creatorName>Keskus, Ayse Gokce</creatorName> <givenName>Ayse Gokce</givenName> <familyName>Keskus</familyName> </creator> <creator> <creatorName>Arslan-Ergul, Ayca</creatorName> <givenName>Ayca</givenName> <familyName>Arslan-Ergul</familyName> </creator> <creator> <creatorName>Konu, Ozlen</creatorName> <givenName>Ozlen</givenName> <familyName>Konu</familyName> </creator> <creator> <creatorName>Kafaligonul, Hulusi</creatorName> <givenName>Hulusi</givenName> <familyName>Kafaligonul</familyName> </creator> <creator> <creatorName>Adams, Michelle M.</creatorName> <givenName>Michelle M.</givenName> <familyName>Adams</familyName> </creator> </creators> <titles> <title>Long-Term Acetylcholinesterase Depletion Alters The Levels Of Key Synaptic Proteins While Maintaining Neuronal Markers In The Aging Zebrafish (Danio Rerio) Brain</title> </titles> <publisher>Aperta</publisher> <publicationYear>2023</publicationYear> <dates> <date dateType="Issued">2023-01-01</date> </dates> <resourceType resourceTypeGeneral="Text">Journal article</resourceType> <alternateIdentifiers> <alternateIdentifier alternateIdentifierType="url">https://aperta.ulakbim.gov.tr/record/270528</alternateIdentifier> </alternateIdentifiers> <relatedIdentifiers> <relatedIdentifier relatedIdentifierType="DOI" relationType="IsIdenticalTo">10.1159/000534343</relatedIdentifier> </relatedIdentifiers> <rightsList> <rights rightsURI="http://www.opendefinition.org/licenses/cc-by">Creative Commons Attribution</rights> <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights> </rightsList> <descriptions> <description descriptionType="Abstract"><p>Introduction: Interventions targeting cholinergic neurotransmission like acetylcholinesterase (AChE) inhibition distinguish potential mechanisms to delay age-related impairments and attenuate deficits related to neurodegenerative diseases. However, the chronic effects of these interventions are not well-described. Methods: In the current study, global levels of cholinergic, cellular, synaptic, and inflammation-mediating proteins were assessed within the context of aging and chronic reduction of AChE activity. Long-term depletion of AChE activity was induced by using a mutant zebrafish line and they were compared with the wildtype group at young and old ages. Results: Results demonstrated that AChE activity was lower in both young and old mutants and this decrease coincided with a reduction in ACh content. Additionally, an overall age-related reduction in AChE activity and the AChE/ACh ratio was observed, this decline was more prominent in wildtype groups. The levels of an immature neuronal marker were upregulated in mutants, while a glial marker showed an overall reduction. Mutants had preserved levels of inhibitory and presynaptic elements with aging, whereas glutamate receptor subunit levels declined. Discussion/Conclusion: Long-term AChE activity depletion induces synaptic and cellular alterations. These data provide further insights into molecular targets and adaptive responses following the long-term reduction of AChE activity that was also targeted pharmacologically to treat neurodegenerative diseases in human subjects.</p></description> </descriptions> </resource>
Görüntülenme | 0 |
İndirme | 0 |
Veri hacmi | 0 Bytes |
Tekil görüntülenme | 0 |
Tekil indirme | 0 |